Total Payments
$49,061
2024 Payments
$2,172
Companies
70
Transactions
949
Medicare Patients
10,510
Medicare Billing
$1.8M

Payment Breakdown by Category

Food & Beverage$24,738 (50.4%)
Other$16,490 (33.6%)
Travel$4,691 (9.6%)
Consulting$2,250 (4.6%)
Education$891.70 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $24,738 911 50.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,490 13 33.6%
Travel and Lodging $4,691 21 9.6%
Consulting Fee $2,250 1 4.6%
Education $891.70 3 1.8%

Top Paying Companies

Company Total Records Latest Year
Pernix Therapeutics Holdings, Inc. $15,699 35 $0 (2018)
Abbott Laboratories $9,117 250 $0 (2024)
PFIZER INC. $3,606 66 $0 (2024)
Boston Scientific Corporation $3,307 62 $0 (2024)
Lilly USA, LLC $2,277 3 $0 (2020)
Spinal Simplicity, LLC $2,114 7 $0 (2024)
Nevro Corp. $1,648 47 $0 (2022)
Vertiflex, Inc. $1,400 18 $0 (2019)
ABBVIE INC. $775.78 34 $0 (2024)
Medinc of Texas $764.00 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,172 67 Abbott Laboratories ($1,412)
2023 $2,836 88 Abbott Laboratories ($1,359)
2022 $3,323 107 Abbott Laboratories ($1,945)
2021 $6,328 154 Spinal Simplicity, LLC ($2,082)
2020 $4,557 91 Lilly USA, LLC ($2,250)
2019 $4,835 143 Abbott Laboratories ($1,278)
2018 $19,177 169 Pernix Therapeutics Holdings, Inc. ($14,366)
2017 $5,833 130 PFIZER INC. ($2,836)

All Payment Transactions

949 individual payment records from CMS Open Payments — Page 3 of 38

Date Company Product Nature Form Amount Type
02/27/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $23.18 General
Category: BOTOX THERAPEUTIC
02/22/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $19.45 General
Category: CEREBROVASCULARCNS
02/22/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $16.21 General
Category: Analgesic
02/14/2024 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $149.28 General
Category: Neuromodulation
02/07/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $14.32 General
Category: NEUROSCIENCE
02/07/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $12.14 General
Category: Neuromodulation
02/02/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $3.01 General
Category: Neuromodulation
01/31/2024 Bioventus LLC DUROLANE (Device) Food and Beverage In-kind items and services $35.52 General
Category: ORTHOPEDICSORTHOPEDIC SURGERY
01/25/2024 ABBVIE INC. UBRELVY (Drug), BOTOX Food and Beverage In-kind items and services $21.36 General
Category: NEUROSCIENCE
01/22/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $9.63 General
Category: Neuromodulation
01/22/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $7.95 General
Category: Neuromodulation
01/22/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $6.88 General
Category: Neuromodulation
01/22/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $5.14 General
Category: Neuromodulation
01/22/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $4.53 General
Category: Neuromodulation
01/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $24.61 General
Category: Gastroenterology
01/10/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $14.27 General
Category: NEUROSCIENCE
01/08/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $20.94 General
Category: PAIN
12/29/2023 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $132.55 General
Category: Neuromodulation
12/29/2023 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $11.91 General
Category: Neuromodulation
12/29/2023 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $10.83 General
Category: Neuromodulation
12/28/2023 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $7.69 General
Category: Neuromodulation
12/21/2023 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $2.67 General
Category: Neuromodulation
12/20/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $25.25 General
Category: Gastroenterology
12/19/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $19.70 General
Category: Gastroenterology
12/14/2023 AbbVie Inc. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $4.84 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 25 2,665 4,143 $3.5M $470,982
2022 24 2,248 3,915 $3.0M $384,775
2021 25 2,289 4,648 $3.1M $412,894
2020 27 3,308 7,106 $4.2M $509,596
Total Patients
10,510
Total Services
19,812
Medicare Billing
$1.8M
Procedure Codes
103

All Medicare Procedures & Services

103 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 385 462 $600,600 $110,711 18.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 371 1,040 $795,631 $99,269 12.5%
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 264 402 $522,600 $78,298 15.0%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 699 969 $581,400 $58,464 10.1%
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 191 242 $314,600 $37,137 11.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 210 346 $178,189 $22,464 12.6%
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level Facility 2023 82 106 $85,582 $10,153 11.9%
64635 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint Facility 2023 35 42 $67,153 $8,586 12.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 84 84 $64,233 $7,320 11.4%
63650 Insertion of spinal neurostimulator electrode array through skin Facility 2023 13 25 $73,974 $6,143 8.3%
64633 Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint Facility 2023 21 24 $38,905 $4,976 12.8%
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level Facility 2023 25 42 $27,380 $4,016 14.7%
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance Facility 2023 42 52 $31,271 $3,915 12.5%
64490 Injection of upper or middle spine facet joint using imaging guidance, single level Facility 2023 15 27 $20,559 $2,850 13.9%
62323 Injection of substance into lower spine canal using imaging guidance Facility 2023 28 34 $24,231 $2,638 10.9%
64636 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint Facility 2023 34 41 $17,533 $2,549 14.5%
64494 Injection of lower or sacral spine facet joint using imaging guidance, second level Facility 2023 25 42 $15,835 $2,258 14.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 17 17 $19,799 $2,159 10.9%
64484 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level Facility 2023 39 47 $17,509 $1,883 10.8%
64634 Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint Facility 2023 20 23 $11,264 $1,645 14.6%
64491 Injection of upper or middle spine facet joint using imaging guidance, second level Facility 2023 13 23 $10,056 $1,319 13.1%
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 15 15 $19,500 $1,071 5.5%
20610 Aspiration and/or injection of fluid from large joint Facility 2023 12 13 $5,576 $512.43 9.2%
95972 Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming Facility 2023 11 11 $3,261 $347.38 10.7%
77002 Fluoroscopic guidance for needle placement Facility 2023 14 14 $2,803 $297.78 10.6%

About Dr. Raimy Amasha, MD

Dr. Raimy Amasha, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1760643498.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raimy Amasha, MD has received a total of $49,061 in payments from pharmaceutical and medical device companies, with $2,172 received in 2024. These payments were reported across 949 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($24,738).

As a Medicare-enrolled provider, Amasha has provided services to 10,510 Medicare beneficiaries, totaling 19,812 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.

Practice Information

Products in Payments

  • SILENOR (Drug) $10,561
  • ZOHYDRO ER (Drug) $5,138
  • PROCLAIM (Device) $4,553
  • EMBEDA (Drug) $2,737
  • Proclaim Family of SCS IPGs (Device) $2,527
  • HA MINUTEMAN G3-R (Device) $2,114
  • SPECTRA WAVEWRITER (Device) $1,750
  • Superion ISS (Device) $1,400
  • Proclaim IPG (Device) $1,286
  • Senza II (Device) $1,009
  • NURTEC ODT (Drug) $710.74
  • Intracept (Device) $548.79
  • Senza Spinal Cord Stimulation System (Device) $477.99
  • SCS IPGs (Device) $461.74
  • Morphabond ER (Drug) $427.58
  • Horizant (Drug) $398.14
  • UBRELVY (Drug) $364.66
  • RELISTOR (Drug) $364.58
  • Superion (Device) $351.56
  • XTAMPZA (Drug) $350.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Austin